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Abstract
Background: Several chronic conditions leading to skeletal muscle dysfunction are known to be associated with 
changes in the expression of myosin heavy chain (MHC) isoforms at both the mRNA and protein level. Many of these 
conditions are modelled, pre-clinically, in the guinea pig due to similar disease onset and progression to the human 
condition, and their generally well-characterised anatomy. MHC composition is amenable to determination by protein 
and mRNA based methodologies, the latter quantifying the expression of MHC isoform-specific gene transcripts 
allowing the detection of earlier, and more subtle changes. As such, the MHC mRNAs, and specific oligonucleotide 
primers of all common laboratory species have been available for some time. However, due to incomplete genomic 
annotation, assessment of guinea pig MHC mRNA expression has not been previously possible, precluding the full 
characterisation of early changes in skeletal muscle in response to disease and disease modulation.
The purpose of this study was to characterise the multigenic structure of the sarcomeric MHC family in the guinea pig, 
and to design and validate specific oligonucleotide primers to enable the assessment of the predominant adult-
muscle associated MHC mRNAs in relevant disease models.
Results: Using a combination of ligase-mediated rapid amplification of 5' and 3' cDNA ends (RACE) and bioinformatics, 
mRNAs to the four main skeletal-muscle isoforms of MHC were determined. Specific oligonucleotide primers were 
designed, and following verification of their specificity, found to successfully determine the expression of each MHC 
mRNA independently.
Conclusions: Because of their utilisation in the in vivo modelling of disease, there is a requirement to develop 
molecular methods that accurately differentiate the different MHC mRNAs in the guinea pig to enable rapid profiling of 
muscle composition in appropriate disease models. The methods developed here are suitable for the characterisation 
of muscle MHC expression at the molecular level from animal tissue samples and biopsy material. The publication of 
these specific oligonucleotide primers for the guinea pig MHC variants will enable researchers to rapidly and accurately 
quantify acute changes in MHC mRNA expression in either developmental or in guinea pig disease models where a 
marker of altered skeletal muscle function is required.
Background
Skeletal muscle tissue is able to adapt to various stimuli
including neuronal, hormonal, mechanical and nutri-
tional signals [1]. Termed "plasticity", this process of
adaption is made possible, in part, by the existence of
multiple isoforms of myosin heavy chain (MHC), which
comprise a family of molecular motors able to modulate
the speed of skeletal muscle contraction [1]. The sarco-
meric MHC family consists of at least eleven isoforms,
eight of which are encoded by distinct genes located in
two multigenic regions on two separate chromosomes
[2]. Six genes are encoded by a 300 - 600 Kb segment on
human and mouse chromosomes 17 and 11 respectively,
in a cluster arrangement in the order MyH3/MyH2,
MyH1/MyH 4, MyH 8/MyH13. The MyH2, MyH1 and
MyH4 genes encode the protein isoforms commonly
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termed MHC IIA, IIX and IIB. The slow-type MHC skel-
etal muscle (Type 1 or MyH7β) and cardiac (MyHα) iso-
forms are located independently from the other striated
muscle associated isoforms on chromosome 14 in both
species [2]. The remaining three MyH genes, named
MyH14, MyH15 and MyH16 have only recently been
described [3] and are found on human chromosomes 20,
3 and 7 respectively. Of the eleven sarcomeric isoform
genes of MHC, four are known to be expressed in adult
skeletal muscle: one "slow-twitch" (Type I) muscle-associ-
ated MHC isoform and three "fast-twitch" (Types IIA, IIX
and IIB) muscle-associated isoforms. The expression of
MHC IIB protein is species-specific and has been
described in marsupials and various laboratory strains
[4], but is absent in human [5], primate, bovine, canine,
and feline locomotor muscles [6].
Several chronic pathological conditions leading to skel-
etal muscle dysfunction are known to be associated with
changes in the relative proportions of MHC of various
skeletal muscles. Age-related sarcopenia has been charac-
terised by a decrease in MHC IIB and IIX protein leading
to an overall transition from fast to slower muscle fibre
characteristics [7]. Osteoarthritis has been associated
with the loss of MHC IIX and IIA fibres [8] in the quadri-
ceps muscle, whilst chronic heart failure (CHF) has been
associated with a significant decrease in the cardiac com-
plement of MHC Iα [9]. Changes in skeletal muscle prop-
e r t i e s  h a v e  o n l y  r e c e n t l y  b e e n  d e s c r i b e d  i n  c h r o n i c
obstructive pulmonary disease (COPD) patients, the dia-
phragms of which were found to have reduced MHC IIX
protein [10].
In order to understand the complex molecular events
involved in the initiation and progression of such disor-
ders, and in the development of pharmacological agents
that modulate disease, animal models that attempt to
mimic human pathology are often utilised. The labora-
tory guinea pig (Cavia porcellus) is used for in vivo mod-
elling of chronic disorders including heart failure [11],
osteoarthritis [12] and COPD [13].
In attempting to monitor changes in MHC expression
as markers for skeletal muscle contractile function, a
number of methods exist including traditional his-
tochemical studies [14], electrophoretic separation of
MHC [15,16], and the use of MHC-specific anti-sera [7].
Although well characterised, these methodologies focus
on the determination of MHC protein and are therefore
restricted to the assessment of changes post-translation.
More recently, molecular-based methodologies have
focused on the quantification of MHC isoform-specific
mRNA, allowing the detection of global changes in MHC
gene expression that may precede changes in MHC pro-
tein, although translational control mechanisms
undoubtedly exist. Thus far, MHC gene expression has
been quantified in man [17], the rat [18] and various
other laboratory species. However, despite their use as an
in vivo model of human disease associated with muscle
dysfunction, due to incomplete genomic annotation,
assessment of guinea pig MHC mRNA expression has not
been previously possible. Moreover, it appears that
attempts to resolve guinea pig MHC isoform-specific
proteins by electrophoretic separation have also proved
unsuccessful thus precluding the characterisation of
changes in skeletal muscle in response to disease and dis-
ease modulation.
Because of their utilisation in the in vivo modelling of
disease, there is a requirement to develop molecular
methods that accurately differentiate the different MHC
mRNAs in the guinea pig to enable rapid profiling of
muscle composition in appropriate animal disease mod-
els. Moreover, given that little is known about this species
with respect to skeletal muscle MHC expression, the
determination of MHC mRNAs is important both in
advancing our knowledge of the guinea pig and in the
comparison of MHC expression profiles with other
rodent species.
The purpose of this study was therefore to characterise
the multigenic structure of the sarcomeric MHC gene
family in the Cavia porcellus, and to design and validate
specific oligonucleotide primers to enable the assessment
of the four sarcomeric MHC mRNAs expressed in adult
skeletal muscle.
Results and Discussion
Study Overview
Through a combination of RNA ligase-mediated rapid
amplification of 5' and 3' cDNA ends (RACE) and bioin-
formatics, we aimed to characterise the myosin heavy
chain (MHC) multigene family predominantly expressed
in guinea pig skeletal muscle (Cavia porcellus), and sub-
sequently design specific oligonucleotide primer pairs for
the quantification of gene expression of the four major
skeletal muscle-associated MHC isoforms.
Generation of a Short Fragment of Guinea Pig cDNA
In the first instance, a short fragment (626 bp) of guinea
pig sequence was generated from quadriceps cDNA using
primer pair GP_626 bp (Table 1) targeting a region
between exons 5 and 10 that is completely conserved
across the three "fast" isoforms of myosin heavy chain in
related species (Rattus norvegicus and  Mus musculus)
using endpoint PCR. Following cloning and sequencing,
this novel sequence was used to interrogate the partially
annotated Cavia porcellus gDNA database using BLAT
(Ensemble release 56) to include sequences from Rattus
norvegicus,  Mus musculus and Cavia porcellus. BLAT
analysis revealed this sequence to be located at the 5' of
gene MyH2 in both Rattus norvegicus and Mus musculus.Tonge et al. BMC Molecular Biology 2010, 11:52
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Determining the Genomic Location of Other Members of 
the Myosin Heavy Chain gene Family
In all other species described, the myosin heavy chain
family of genes is located on a single chromosome and
arranged in a head to tail fashion in the order MyH3/
MyH2, MyH1/MyH 4 and MyH8/MyH13 with the excep-
tion of the cardiac (MyH7α) and slow skeletal muscle iso-
forms (MyH7β) which are located on a distant
chromosome [2]. Using this knowledge, and the previ-
ously determined location of the MyH2 gene as a starting
p o i n t ,  w e  w e r e  a b l e  t o  a d v a n c e  a l o n g  t h e  g e n o m i c
sequence data (Ensemble release 56), aligning individual
exons from both Rattus norvegicus and  Mus musculus
MyH1, MyH2, MyH3, MyH4, MyH8 and MyH13 cDNAs
(Table 2) to the guinea pig gDNA database, thus spatially
mapping out the arrangement of genes in the guinea pig
(Figure 1). During the course of this study, a full length
cDNA pertaining to Cavia porcellus MyH7 was anno-
tated in Ensemble release 56. We therefore focused on
characterising the remaining fast MHC genes.
Determination of the Gene Boundaries of MyH1, 2 and 4 by 
5' and 3' Race
To accurately determine the boundaries of each of the
adult skeletal muscle associated MHC isoforms, the mul-
tiple exonic alignments (as previously described) from
MyH1, MyH2 and MyH4 were obtained from the
genomic sequence, and the newly annotated putative
sequence data subjected to 5' and 3' RACE using primers
designed to amplify all three fast isoforms (Table 1). RNA
derived from three different muscles was used in the 5'
and 3' RACE protocol to enrich for the various MHC
gene transcripts since Extensor digitorum longus is
known to predominantly express MyH1 and MyH4;
Soleus MyH2 and MyH7 whilst Quadriceps is reported to
express all four isoforms based on data from previous his-
tochemical studies [19].
Both 5' and 3' RACE protocols resulted in the forma-
tion of specific race products which were subsequently
cloned and sequenced. For each MHC transcript, 3'
RACE sequences encoded approximately 400 bp of cod-
ing sequence followed by the 3' UTR, whilst 5' RACE
sequences encoded approximately 300 bp of coding
sequence followed by the 5' UTR. The 3' and 5' untrans-
lated regions were used to identify the start and end of
transcription for MyH 1, 2, and 4 (Figure 2). For all three
genes or RACE products assessed, the resulting novel 5'
UTRs encoded three distinct exons, the first two of which
fell within a 100-200 bp region, the third was located
more distantly and encoded the signal to instigate trans-
lation (ATG in this instance). The novel 3' UTRs encoded
a single exon starting immediately downstream of the
stop codon (TAA  in MyH1 and MyH4, and TGA  in
MyH2) (Figure 2). All novel 3' and 5' sequences were
deposited in GenBank (see Table 2 for accession num-
bers)
Design of Specific Oligonucleotide Primers
Primers for MyH7β encoded mRNA were designed at the
3' of the coding sequence as determined by the full length
MyH7β cDNA ENSCPOG00000004208 (Ensemble
release 56). Due to the high degree of conservation
between the remaining fast variant mRNAs, oligonucle-
otide primers were designed in the newly described 3'
UTR where more divergence was noted, as determined by
3' RACE (Figure 3). Due to this high degree of homology,
the fast MHC mRNA primers sets (MyH13'UTR,
MyH23'UTR and MyH43'UTR) were subjected to a fur-
ther assessment of specificity. Vectors containing the 3'
UTRs pertaining to MyH1, 2 and 4 were linearised by
Bgl1 endonuclease digestion (NEB), adjusted to 2 ng/μl
and serially diluted. Five-fold serial dilutions were then
mixed 1:1 (vol/vol) with molecular biology grade water
(control) or a combination of the two competing vectors
at a concentration of 0.4 ng/μl. Following quantitative
Table 1: Comprehensive list of oligonucleotide primers used for RACE and quantitative PCR
Primer Name Forward (5' - 3') Reverse (5' - 3') Tm (°C) Expected 
Product (bp)
GP_626 bp TGTCATCCAGTACTTTGCAACAA TGAGCAGGTCAGCAGAGTTC 60 626
Reverse_GSP_2 - CAGGCTGCGTAACGCTCTTTGAGGTTGT 68 -
Reverse_Nested_GSP_2 - CTCGTGCAGGTGGGTCATCATGG 68 -
Forward_GSP_2 CATGATGGCCGAGGAGCTGAAGAAG - 68 -
Forward_Nested_GSP_2 AAGGGCGGCAAGAAGCAGATCCAGAAG - 68 -
MyH7Term3' AAGTATCGCAAGGCTCAA CCTTTCCTTAATTCCAAGC 55 129
MyH13'UTR TTCATCCAAATGCAGGAAAG TCTTTATCTCAAAAGTCATAAATACAA 55 90
MyH23'UTR TGTGGAATGACCAGAGCAAG CCTTTGCAATAGGGTAGGACA 55 85
MyH43'UTR TCCATCTACTGCTGCAACG ACTCTGCAGATTTTATTTCCTTG 55 93Tonge et al. BMC Molecular Biology 2010, 11:52
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PCR using the SYBR-Green detection system, no cross-
reaction was observed between any of the primer pairs
tested (Figure 4).
Assessment of Three Distinct Guinea Pig Skeletal Muscles 
by Quantitative PCR
In order to validate further the utility of the oligonucle-
otide primers designed, three distinct guinea pig muscles
were analysed in terms of their MHC mRNA expression.
Based on histochemical studies of numerous laboratory
species, including the guinea pig, Soleus is known to be a
slow, postural muscle with a predominance of MHC I and
MHC IIA muscle fibres and therefore by inference MyH7
and MyH2 mRNA variants. In contrast, Extensor digito-
rum longus has a faster contractile phenotype and a pre-
dominance of MHC IIX and MHC IIB muscle fibres
(encoded by MyH1 and MyH4 mRNAs). Finally, Quadri-
ceps femoris is known to express all muscle fibre types
and therefore all variants of myosin heavy chain mRNA
[19]. Quantitative PCR analysis of guinea samples from
the above muscles revealed expression patterns as
expected. MyH7 and MyH2 were most abundantly
detected in the slow, postural Soleus. MyH1 and MyH4
were detected most abundantly in the fast twitch Exten-
sor digitorum longus, whilst all four transcripts were
Table 2: List of gene names, sequence attributes and accession numbers
Species Gene Name Accession Number Comments
Mus musculus MyH1 NM_030679.1 Full Length CDS
MyH2 NM_001039545.2 Full Length CDS
MyH3 NM_001099635.1 Full Length CDS
MyH4 NM_010855.2 Full Length CDS
MyH8 NM_177369.3 Full Length CDS
MyH13 NM_001081250.1 Full Length CDS
Rattus norvegicus MyH1 NM_001135158.1 Full Length CDS
MyH2 NM_001135157.1 Full Length CDS
MyH3 NM_012604.1 Full Length CDS
MyH4 NM_019325.1 Full Length CDS
MyH8 XM_001080186.1 Full Length CDS
MyH13 XM_001078857.1 Full Length CDS
Cavia porcellus MyH1 GU288593 5' CDS + UTR
MyH1 GU288596 3' CDS + UTR
MyH2 GU288594 5' CDS + UTR
MyH2 GU288597 3' CDS + UTR
MyH4 GU288595 5' CDS + UTR
MyH4 GU288598 3' CDS + UTR
MyH7β ENSCPOG00000004208 Full Length CDS
Figure 1 Spatial arrangement of the multigenic myosin heavy chain (MHC) family in the laboratory guinea pig (Cavia porcellus) as deter-
mined through the retrieval of MHC isoform specific genes (MyH) from various species using multiple BLAST and subsequent alignment 
(ClustalW2). I.G - Intergenic region size (Kb); Protein - protein product of each gene.
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detected at intermediate levels in the Quadriceps muscle
(Figure 5)
Conclusions
In this study, we partially characterised the structure of
the myosin heavy chain multigene family in the common
guinea pig (Cavia porcellus). As with other species stud-
ied, the MHC genes were found to be located in a head-
to-tail fashion in the order MyH3/MyH2, MyH1/, MyH 4
and MyH8/MyH13. Although exact chromosomal loca-
tions are still unknown due to restricted genomic annota-
tion, we found the MyH7β gene to be located in a distinct
Figure 2 Illustration of the relative 5' and 3' genomic structure of guinea pig MyH 1 (A), 2 (B) and 4 (C) derived from 5' and 3' RACE products 
indicating the transcription start site and exon positions. Open boxes - individual exons; Thick black arrow - transcription start site; Thick grey 
arrow - translation start site; Numbers indicate the position relative to the transcription start site in the respective gene.
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contig, consistent with its location on a distal chromo-
some in other species. We have designed and tested spe-
cific oligonucleotide primers for MyH7β, MyH2, MyH1
and MyH4 mRNA variants, and for the first time, are able
to successfully differentiate and quantify the adult skele-
tal muscle associated MHC variants by quantitative PCR
analysis.
The methods developed here are suitable for the char-
acterisation of muscle myosin heavy chain complement at
the molecular level from animal tissue samples and
biopsy material. Furthermore, the publication of these
specific oligonucleotide primers for the guinea pig myo-
sin heavy chain variants will enable researchers to rapidly
and accurately quantify acute changes in MHC expres-
sion in either developmental or in guinea pig disease
models where a marker of altered skeletal muscle func-
tion is required.
Methods
Extraction of Total RNA
Extensor digitorum longus, soleus and quadriceps femoris
were carefully dissected from 3 month old Dunkin Hart-
ley strain guinea pigs (Harlan, UK) (n = 6) and immedi-
ately snap frozen in liquid nitrogen. Total RNA was
extracted from 100 mg of sample using TRIzol regent
(Invitrogen) according to standard procedure. Contami-
nating genomic DNA was removed by DNase digestion
(Promega) as specified by the manufacturers. The result-
ing total RNA was resuspended in molecular biology
grade water (Promega). All RNA was stored at -80°C
prior to use.
Reverse Transcription
First strand complementary DNA (cDNA) was reverse
transcribed from 1 μg total RNA using random hexamers
and Moloney murine leukemia virus reverse tran-
scriptase (MMLV) in a final volume of 25-μl as described
by the manufacturer (Promega).
Primer Design
All primers were designed using Primer3 software and
sourced from MWG Eurofins Operon. To enforce speci-
ficity, all base mis-matches were directed towards the 5'
end of each oligonucleotide primer.
Figure 4 Specificity of quantitative PCR reactions for each target MHC gene transcript. Linearised vectors containing the 3' UTRs pertaining to 
MyH1 (A), 2 (B) and 4 (C) were adjusted to 2 ng/μl and serially diluted. Five-fold serial dilutions were then mixed 1:1 (vol/vol) with molecular biology 
grade water (control) or a combination of the two competing vectors at a concentration of 0.4 ng/μl and subjected to quantitative PCR with the re-
spective MyH primer sets in triplicate. No cross-reaction was noted between any of the MyH primer sets and competing vectors. Black line - control 
reaction; Grey line - reaction with competitor vectors added; Axes - Log 10 vector concentration against crossing point (Cp); Dashed line - predicted 
observation should cross-reaction occur.Tonge et al. BMC Molecular Biology 2010, 11:52
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Polymerase Chain Reaction (PCR)
End-point PCR reactions were performed on 5 μl cDNA
in AmpliTaq Gold Buffer (ABI), 1.5 mM MgCl 2, 0.2 mM
dNTP mix (Promega), 0.25 mM forward and reverse oli-
gonucleotide primers (Eurofins) and 1.25 U AmpliTaq
(ABI) in a total reaction volume of 50 μl. Cycling parame-
ters were 94°C for 10 minutes; 35 cycles of 94°C for 30 s,
60°C for 30 s, 72°C for 30 s followed by a final extension at
72°C for 10 minutes. PCR products were resolved on 1.2%
(w/v) agarose gel (Melford), stained for 30 minutes in
ethidium bromide (0.5 μg/mL) and visualised under a UV
light source.
Quantitative PCR reactions were performed in tripli-
cate on 5 μl cDNA in SYBR 1 Master mix (Roche), 0.25
mM forward and reverse primers in a final volume of 15
μl. Cycling parameters were 95°C for 5 minutes prior to;
35 cycles of 10 seconds 95°C, 10 seconds 55°C and 30 sec-
onds at 72°C. Single signal acquisition was set to read at
72°C. All reactions were run on a 384-well microplate on
a LightCycler LC480 (Roche) configured for SYBR green
determination as specified by the manufacturers. Melt
curve analysis was performed at the end of each com-
pleted analysis run to ensure only the specific product
was amplified. All quantitative PCR data were normalised
to the total first strand cDNA concentration following
reverse transcription using OliGreen (Invitrogen). Oli-
Green determination has been previously validated as an
alternative to the use of traditional housekeeping genes
[20,21].
Cloning
Where indicated, PCR products were cloned using the
TOPO TA cloning system (Invitrogen) according to the
manufacturer's standard protocol. Inserts were con-
firmed by sequencing which was bidirectional, and
undertaken by GeneService (Nottingham) using primers
in the vector sequences.
RNA Ligase-Mediated Rapid Amplification of 5' and 3' cDNA 
Ends (Race)
RACE was carried out on 3000 ng of total RNA using the
GeneRacer Kit (Invitrogen). All procedures were carried
out in accordance with the manufacturer's instructions.
5'RACE nested PCR reactions were carried out using
primer Reverse_GSP_2 directed against exon 2 (5'-CAG-
GCTGCGTAACGCTCTTTGAGGTTGT-3') for the first
round and primer Reverse_Nested_GSP_2 located 36 bp
Figure 5 Expression of MyH7 (A), MyH2 (B), MyH1 (C) and MyH4 (D) transcripts in three distinct skeletal muscles as determined by quanti-
tative PCR reactions in triplicate normalised to total first-strand cDNA concentration. White bar - Soleus; Grey bar - Extensor digitorum longus; 
Black bar - Quadriceps. Error bars indicate mean normalised expression + S.E.M; n = 6.Tonge et al. BMC Molecular Biology 2010, 11:52
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upstream of primer Reverse_GSP_2 (5'-CTCGTGCAG-
GTGGGTCATCATGG-3'), for the second round.
3'RACE nested PCR reactions were carried out using
primer Forward_GSP_2 directed against exon 36 (5'-
CATGATGGCCGAGGAGCTGAAGAAG-3') for the
first round and primer Forward_Nested_GSP_2 located
105 bp downstream of primer Reverse_GSP_2 (5'-
AAGGGCGGCAAGAAGCAGATCCAGAAG-3'), for
the second round. PCR generated products were cloned
using the TOPO TA cloning kit for sequencing (Invitro-
gen) and sequenced (Geneservice).
Sequence Alignment and Bioinformatics
Due to the lack of sequence annotation within the Cavia
porcellus genome, likely conserved regions were located
by obtaining cDNA sequences pertaining to MyH1,
MyH2 and MyH4 mRNA variants (encoding MHC IIX,
IIA and IIB respectively) from mouse (Mus musculus)
and rat (Rattus norvegicus) via Ensemble (release 56). All
sequences were aligned using the ClustalW2 application
(EBI) configured for DNA analysis.
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